Entac Medical
Germantown
About Entac Medical
Entac Medical is developing medical devices for predictive and diagnostic medicine based on a novel platform technology, audio spectral analysis. Its first application, PrevisEA, is a late stage, Class II noninvasive, disposable device that is clinically proven to predict post-operative ileus (POI) in surgical patients (GI paralysis occurs 2-6 days after surgery in 25% of patients). Prediction of ileus risk improves treatment protocols and patient outcomes while reducing readmissions and saving hospitals millions of dollars in unnecessary treatment costs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $3.3M
- Funding stage: Early Stage Venture
- Last round: Series B (Feb 2020)
- Website: entacmedical.com
Industries & Categories
Analytics, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/entac-medical-134955 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.